Member Info for davwal

fight fire with fire, no point *****footing around. good for them. boo ain't the answer full stop.

Schwartz acted (as required by regulation) responsibly in the interests of the company, its shareholders and customers. No legal action will be advised at this time in my view given the imminent relisting which will provide an unequivocal judgement by interested parties on the situation. Bloody well done, that man.

Our cusps runneth over...

The crux is re-listing. I’m disappointed they still won’t say exactly what is standing in the way of that.

As long as a piece of string..

Suddenly, BH wants to demonstrate he’s Action Man! Strange that. Now get it trading Bob, trading pdq!

The delay in trading could well have been Bob’s strategy to force BOO’s hand. He ain’t stupid..!

In the light of today’s news, other hands might be forced. We could well see a rival bid (assuming one being made by BOO) very soon, particularly from within the industry.

AIM can only take account of the current situation where the company in question has the requisite board, not that other parties might want changes made at some point. That said, AIM could well consider it in shareholders’ interest to relist asap.

Just a thought, Tertiary to preset day might include a lot of heavy and/or immature crude oil.

The new non-execs look a very good match for the company at this sensitive point in its development. All in all, the building blocks for steady, but but profitable, recovery are being laid.

With regard to the revised, lower valuation of Medichem, given the use of the term ‘material’ to describe the difference to the initial figure, while it’s yet to be concluded I’d guess the company has a new total valuation 8-12 mil short of the previous. If that sort of figure materialises it will clearly by highly beneficial to Rev’s overall financial picture. I’d love to be a fly on the wall during said negotiations with TW!

Review of working capital sounds like code for how do they best raise funds, before or after relisting.

After Bob’s previous.wording on the topic, the carefully minimal reference to and avoidance of detail on the process of re admittance to trading is weird - and frankly concerning. It’s obviously not entirely in REVB’s hands, but they must know where they are at along the process and what obstacles remain. At the moment it potentially looks some way off.

Ah yes - noted.

Couldn’t help but wonder whether this particular customer of REVB was possibly one of those that agreed questionable practices with previous management concerning placement of unnecessary orders.

Too early to be considering a dual list, in my view. The company needs to prove itself through normal business, to at least include this year’s results. Quite a few US companies with mainly US operations list on LSE only, without apparent difficulties. They certainly need to update the market on the new management’s business strategy to make it very clear the business has both realistic short/medium term objectives in place and an ambitious development plan for the longer term.

4p read my lips

Ugh, no thanks.

Artrader, well done for delivering up your first post about REVB. Your writing style is, well, a bit breathlessly romantic - Mills &Boon even - but after all, you have had at least 10 months to guild your flowery prose. Made me smile, though.

Have been travelling so limited opportunity to digest everything. However, it’s looks to me like the sp crash more than compensated for the situation now revealed, and with business since having expanded and thus apparently doing well under Bob’s smarter management, it seems there’s plenty of reasons to be optimistic in the short, medium and longer terms. I’m optimistic!